Editorial: Differential diagnoses of thyroid neoplasms: Molecular and histological features and the impact on follow-up

COPYRIGHT © 2023 Sorrenti, Lauro, Pironi, Calò and Ulisse. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. TYPE Editorial PUBLISHED 31 January 2023 DOI 10.3389/fonc.2023.1125887

[1]  D. Pironi,et al.  Is Melanoma Progression Affected by Thyroid Diseases? , 2022, International journal of molecular sciences.

[2]  A. Antonelli,et al.  Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer , 2022, International journal of molecular sciences.

[3]  D. Pironi,et al.  In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines , 2022, International Journal of Molecular Sciences.

[4]  D. Pironi,et al.  Thyroid Diseases and Breast Cancer , 2022, Journal of personalized medicine.

[5]  S. Benvenga,et al.  Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies , 2022, Expert opinion on pharmacotherapy.

[6]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[7]  D. Pironi,et al.  Papillary Thyroid Cancer Prognosis: An Evolving Field , 2021, Cancers.

[8]  P. Trimboli,et al.  The Role of CEUS in the Evaluation of Thyroid Cancer: From Diagnosis to Local Staging , 2021, Journal of clinical medicine.

[9]  G. Grani,et al.  Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the Literature , 2021, Diagnostics.

[10]  P. Miccoli,et al.  Recent Trends in Surgical Approach to Thyroid Cancer , 2021, Frontiers in Endocrinology.

[11]  A. Sindoni,et al.  Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study , 2020, Cancers.

[12]  N. P. Ohori,et al.  Molecular testing and thyroid nodule management in North America. , 2020, Gland surgery.

[13]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[14]  C. La Motta,et al.  Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration , 2018, Front. Endocrinol..

[15]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[16]  C. De Vito,et al.  Thyroid Imaging Reporting and Data System Score Combined with the New Italian Classification for Thyroid Cytology Improves the Clinical Management of Indeterminate Nodules , 2017, International journal of endocrinology.

[17]  Sun Wook Cho,et al.  Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers , 2016, PLoS genetics.

[18]  Amy Y. Chen,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[19]  C. De Vito,et al.  Association of Thyroid Diseases with Primary Extra-Thyroidal Malignancies in Women: Results of a Cross-Sectional Study of 6,386 Patients , 2015, PloS one.

[20]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[21]  C. Vito,et al.  Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients , 2014, Breast Cancer Research and Treatment.

[22]  F. Schaefer,et al.  EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology , 2013, Ultraschall in der Medizin.

[23]  Yuri E. Nikiforov,et al.  Diagnostic pathology and molecular genetics of the thyroid , 2012 .

[24]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[25]  V. D’Andrea,et al.  Prognostic significance of the age factor in the thyroid cancer: Statistical analysis , 2004, Journal of surgical oncology.

[26]  M. Ranney,et al.  Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.

[27]  R. Scarrow.  Evolving field , 2018, Nature Sustainability.

[28]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[29]  David Cosgrove,et al.  WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 4. Thyroid. , 2017, Ultrasound in medicine & biology.

[30]  L Nyström,et al.  Statistical Analysis , 2008, Encyclopedia of Social Network Analysis and Mining.

[31]  H. V. Rice.  Basic principles and technology. , 1953, Canadian journal of medical technology.